Titre : | Journal of Psychoactive Drugs, Vol.50, n°1 - January-March 2018 |
Type de document : | Bulletin : Périodique |
Paru le : | 01/03/2018 |
Année de publication : | 2018 |
Format : | 1-93 |
Langues: | Anglais |
Note de contenu : |
CONTENTS:
- Helping smokers quit: New partners and new strategies from the University of California, San Francisco Smoking Cessation Leadership Center. Schroeder S.A., Clark B., Cheng C., Saucedo C.B., p. 3-11. - Feasibility and preliminary effectiveness of varenicline for treating co-occurring cannabis and tobacco use. Adams T.R., Arnsten J.H., Ning Y.M., Nahvi S., p. 12-18. - Regulating cannabis manufacturing: Applying public health best practices from tobacco control. Orenstein D.G., Glantz S.A., p. 19-32. - Rash impulsiveness and negative mood, but not alexithymia or reward sensitivity, differentiate young to middle-aged chronic daily smokers from never-smokers. Lyvers M., Bremner M., Edwards M.S., Thorberg F.A., p. 33-42. - Alcohol and drug use, pain and psychiatric symptoms among adults seeking outpatient psychiatric treatment: Latent class patterns and relationship to health status. Ramo D.E., Bahorik A.L., Delucchi K.L., Campbell C.I., Satre D.D., p. 43-53. - Correlates of high-risk and low-risk alcohol use among college students in Kerala, India. Jaisoorya T.S., Gowda G.S., Nair B.S., Menon P.G., Rani A., Radhakrishnan K.S., et al., p. 54-61. - Perceived treatment need and latent transitions in heroin and methamphetamine polydrug use among people who inject drugs in Tijuana, Mexico. Meacham M.C., Roesch S.C., Strathdee S.A., Gaines T.L., p. 62-71. - Mortality trends among cocaine users treated between 1989 and 2013 in Northern Italy: Results of a longitudinal study. Pavarin R.M., Fioritti A., p. 72-80. - Experiential avoidance and bulimic symptoms among men in residential treatment for substance use disorders: A preliminary examination. Elmquist J., Shorey R.C., Anderson S., Stuart G.L., p. 81-87. - What's in a name? Correlates of ecstasy users knowing or agreeing that Molly is ecstasy/MDMA. Palamar J.J., p. 88-93. |
Cote : | Abonnement |
Lien : | https://www.tandfonline.com/toc/ujpd20/50/1 |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
T. R. ADAMS ;
J. H. ARNSTEN ;
Y. M. NING ;
S. NAHVI
|
Few studies have evaluated treatment for co-occurring cannabis and tobacco use. The objective of this pilot study was to evaluate the feasibility and preliminary effectiveness of varenicline for co-occurring cannabis and tobacco use. Participant[...]
Article : Périodique
State legalization and regulation of cannabis, despite continued federal illegality, is a massive shift in regulatory approach. Manufactured cannabis, including concentrates, extracts, edibles, tinctures, topicals and other products, has receive[...]
Article : Périodique
A total of 852 participants attending 11 centers for addiction treatment in north Italy following problems due to cocaine abuse between 1989 and 2013 were recruited. Two typologies were created: cocaine users (never heroin) (CU) and heroin and c[...]
Article : Périodique
Ecstasy (MDMA) has regained popularity in powder and crystalline form, known as Molly. However, it is unknown whether all Molly users are aware that Molly is ecstasy. A total of 1045 nightclub/festival-attending adults in New York City were surv[...]
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil